A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer

✍ Scribed by A. B. El-Khoueiry, R. K. Ramanathan, D. Y. Yang, W. Zhang, S. Shibata, J. J. Wright, D. Gandara, H. J. Lenz

• Book ID: 113064511
• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 244 KB
• Volume: 30
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-011-9658-9